Showing results (161-170 of 193) with videos related to
Sort By:
Pageof 20
International Journal of Radiation Oncology, Biology, Physics|July 19, 2019
The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012Xue-Song Sun, Sai-Lan Liu, Mei-Juan Luo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2025
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 studyLin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang, et al.Cancer Letters|October 12, 2019
RETRACTED: Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasisShan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2023
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patientsYu-Jing Liang, Qiu-Yan Chen, Jing-Xiao Xu, et al.Radiology|August 2, 2016
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines SurvivalLi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.Journal of Cancer|April 21, 2018
Patterns of Failure and Survival Trends Of 720 Patients with Stage I Nasopharyngeal Carcinoma Diagnosed from 1990-2012: A Large-scale Retrospective Cohort StudyLin-Quan Tang, Tong-Yu Lu, Yang Li, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.Cancer Letters|February 22, 2023
Retraction notice to "Endogenous production of C-C motif chemokine ligand 2 by nasopharyngeal carcinoma cells drives radioresistance-associated metastasis" [Canc. Lett. 468 (2020) 27-40]Shan-Shan Guo, Rui Liu, Yue-Feng Wen, et al.Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.Pageof 20